Shots:

• The Health Canada has approved MANTA vascular closure device as the first commercially available biomechanical device for femoral arterial access site closure
• In the (SAFE MANTA IDE) clinical trial, MANTA Device achieves fast reliable biomechanical closure with rapid hemostasis & can safely and effectively close large bore arteriotomies by TAVR, PEVAR & TEVAR devices in a patients population
• Following the use of 10-20F devices or sheaths (12-25F OD) in endovascular catheterization procedures, the MANTA VCD is approved for closure of femoral artery access sites while shortening the time to hemostasis. The device can save valuable time that offers proven & reproducible results

Ref: Globenewswire | Image: Teleflex